CGON

CG Oncology
CGON

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.97B
EV
$1.28B
Shares Outstanding
79.16M
Beta
-

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$59.89
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About CG Oncology, Inc.

gainify
CGON

CG Oncology, Inc.

CGON

CG Oncology, Inc., an oncolytic immunotherapy company, focuses on developing and commercializing backbone bladder-sparing therapeutics for patients with bladder cancer. The company develops BOND-003 for the treatment of high-risk bacillus calmette guerin (BCG)-unrespo...

Sector

Healthcare

Industry

Biotechnology

CEO

Kuan, Arthur

Employees

113

IPO Date

Headquarters

400 Spectrum Center Drive, Suite 2040, Irvine, California, 92618, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.